{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:36:16Z","timestamp":1790076976793,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41591-026-04505-4","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:02:35Z","timestamp":1782464555000},"page":"2846-2856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Re-administration of AAV-mediated gene therapy for OTOF-related deafness: a single-arm trial"],"prefix":"10.1038","volume":"32","author":[{"given":"Xintai","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-4592","authenticated-orcid":false,"given":"Xiaoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0915-1836","authenticated-orcid":false,"given":"Jiake","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0608-5262","authenticated-orcid":false,"given":"Biyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-4193","authenticated-orcid":false,"given":"Zheng-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0988-9534","authenticated-orcid":false,"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5338-6910","authenticated-orcid":false,"given":"Huawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-434X","authenticated-orcid":false,"given":"Yilai","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"4505_CR1","unstructured":"World Health Organization. Deafness and hearing loss. https:\/\/www.who.int\/health-topics\/hearing-loss (2026)."},{"key":"4505_CR2","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMra050700","volume":"354","author":"CC Morton","year":"2006","unstructured":"Morton, C. C. & Nance, W. E. Newborn hearing screening\u2014a silent revolution. N. Engl. J. Med. 354, 2151\u20132164 (2006).","journal-title":"N. Engl. J. Med."},{"key":"4505_CR3","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1001\/jama.2020.17647","volume":"324","author":"JEC Lieu","year":"2020","unstructured":"Lieu, J. E. C., Kenna, M., Anne, S. & Davidson, L. Hearing loss in children: a review. JAMA 324, 2195\u20132205 (2020).","journal-title":"JAMA"},{"key":"4505_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41576-023-00597-7","volume":"24","author":"C Petit","year":"2023","unstructured":"Petit, C., Bonnet, C. & Safieddine, S. Deafness: from genetic architecture to gene therapy. Nat. Rev. Genet. 24, 665\u2013686 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"4505_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ymthe.2023.02.001","volume":"31","author":"L Jiang","year":"2023","unstructured":"Jiang, L., Wang, D., He, Y. & Shu, Y. Advances in gene therapy hold promise for treating hereditary hearing loss. Mol. Ther. 31, 934\u2013950 (2023).","journal-title":"Mol. Ther."},{"key":"4505_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamaneurol.2025.2053","volume":"82","author":"X Cheng","year":"2025","unstructured":"Cheng, X. et al. Gene therapy vs cochlear implantation in restoring hearing function and speech perception for individuals with congenital deafness. JAMA Neurol. 82, 941\u2013951 (2025).","journal-title":"JAMA Neurol."},{"key":"4505_CR7","doi-asserted-by":"publisher","unstructured":"Al-Moyed, H. et al. A dual-AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock-out mice. EMBO Mol. Med. https:\/\/doi.org\/10.15252\/emmm.201809396 (2019).","DOI":"10.15252\/emmm.201809396"},{"key":"4505_CR8","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1073\/pnas.1817537116","volume":"116","author":"O Akil","year":"2019","unstructured":"Akil, O. et al. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proc. Natl Acad. Sci. USA 116, 4496\u20134501 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4505_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40476-7","volume":"14","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo. Nat. Commun. 14, 4928 (2023).","journal-title":"Nat. Commun."},{"key":"4505_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101154","volume":"31","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates. Mol. Ther. Methods Clin. Dev. 31, 101154 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4505_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306201","volume":"11","author":"J Qi","year":"2024","unstructured":"Qi, J. et al. Preclinical efficacy and safety evaluation of AAV-OTOF in DFNB9 mouse model and nonhuman primate. Adv. Sci. 11, e2306201 (2024).","journal-title":"Adv. Sci."},{"key":"4505_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MAO.0000000000004423","volume":"46","author":"RJ Carlson","year":"2025","unstructured":"Carlson, R. J., Taiber, S. & Rubinstein, J. T. Gene therapy for hearing loss: which genes next? Otol. Neurotol. 46, 239\u2013247 (2025).","journal-title":"Otol. Neurotol."},{"key":"4505_CR13","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","volume":"403","author":"J Lv","year":"2024","unstructured":"Lv, J. et al. AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial. Lancet 403, 2317\u20132325 (2024).","journal-title":"Lancet"},{"key":"4505_CR14","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41591-024-03023-5","volume":"30","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results. Nat. Med. 30, 1898\u20131904 (2024).","journal-title":"Nat. Med."},{"key":"4505_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306788","volume":"11","author":"J Qi","year":"2024","unstructured":"Qi, J. et al. AAV-mediated gene therapy restores hearing in patients with DFNB9 deafness. Adv Sci (Weinh) 11, e2306788 (2024).","journal-title":"Adv Sci (Weinh)"},{"key":"4505_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41576-024-00809-8","volume":"26","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Zhong, J. & Shu, Y. Gene therapy for deafness: we can do more. Nat. Rev. Genet. 26, 225\u2013226 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"4505_CR17","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/s41591-025-03773-w","volume":"31","author":"J Qi","year":"2025","unstructured":"Qi, J. et al. AAV gene therapy for autosomal recessive deafness 9: a single-arm trial. Nat. Med. 31, 2917\u20132926 (2025).","journal-title":"Nat. Med."},{"key":"4505_CR18","doi-asserted-by":"publisher","unstructured":"Valayannopoulos, V. et al. DB-OTO gene therapy for inherited deafness. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2400521 (2025).","DOI":"10.1056\/NEJMoa2400521"},{"key":"4505_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/AUD.0b013e318167b870","volume":"29","author":"CC Dunn","year":"2008","unstructured":"Dunn, C. C., Tyler, R. S., Oakley, S., Gantz, B. J. & Noble, W. Comparison of speech recognition and localization performance in bilateral and unilateral cochlear implant users matched on duration of deafness and age at implantation. Ear Hear. 29, 352\u2013359 (2008).","journal-title":"Ear Hear."},{"key":"4505_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/AUD.0000000000000252","volume":"37","author":"N Ma","year":"2016","unstructured":"Ma, N., Morris, S. & Kitterick, P. T. Benefits to speech perception in noise from the binaural integration of electric and acoustic signals in simulated unilateral deafness. Ear Hear. 37, 248\u2013259 (2016).","journal-title":"Ear Hear"},{"key":"4505_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jcomdis.2009.03.003","volume":"42","author":"A Sharma","year":"2009","unstructured":"Sharma, A., Nash, A. A. & Dorman, M. Cortical development, plasticity and re-organization in children with cochlear implants. J. Commun. Disord. 42, 272\u2013279 (2009).","journal-title":"J. Commun. Disord."},{"key":"4505_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"4505_CR23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","volume":"26","author":"C Leborgne","year":"2020","unstructured":"Leborgne, C. et al. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nat. Med. 26, 1096\u20131101 (2020).","journal-title":"Nat. Med."},{"key":"4505_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct. Target Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target Ther"},{"key":"4505_CR25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.7150\/thno.89380","volume":"14","author":"BP Dhungel","year":"2024","unstructured":"Dhungel, B. P. et al. Understanding AAV vector immunogenicity: from particle to patient. Theranostics 14, 1260\u20131288 (2024).","journal-title":"Theranostics"},{"key":"4505_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno, C. S. et al. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342\u2013347 (2006).","journal-title":"Nat. Med."},{"key":"4505_CR27","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","volume":"108","author":"H Jiang","year":"2006","unstructured":"Jiang, H. et al. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood 108, 3321\u20133328 (2006).","journal-title":"Blood"},{"key":"4505_CR28","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","volume":"107","author":"CD Scallan","year":"2006","unstructured":"Scallan, C. D. et al. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood 107, 1810\u20131817 (2006).","journal-title":"Blood"},{"key":"4505_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","volume":"15","author":"BE Jaski","year":"2009","unstructured":"Jaski, B. E. et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial. J. Card. Fail. 15, 171\u2013181 (2009).","journal-title":"J. Card. Fail."},{"key":"4505_CR30","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/hum.2011.031","volume":"22","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum. Gene Ther. 22, 1389\u20131401 (2011).","journal-title":"Hum. Gene Ther."},{"key":"4505_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/mt.2011.237","volume":"20","author":"DE Bowles","year":"2012","unstructured":"Bowles, D. E. et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol. Ther. 20, 443\u2013455 (2012).","journal-title":"Mol. Ther."},{"key":"4505_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nm1549","volume":"13","author":"F Mingozzi","year":"2007","unstructured":"Mingozzi, F. et al. CD8+ T-cell responses to adeno-associated virus capsid in humans. Nat. Med. 13, 419\u2013422 (2007).","journal-title":"Nat. Med."},{"key":"4505_CR33","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1172\/JCI122372","volume":"128","author":"K Kuranda","year":"2018","unstructured":"Kuranda, K. et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J. Clin. Invest. 128, 5267\u20135279 (2018).","journal-title":"J. Clin. Invest."},{"key":"4505_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","volume":"37","author":"M Arjomandnejad","year":"2023","unstructured":"Arjomandnejad, M., Dasgupta, I., Flotte, T. R. & Keeler, A. M. Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer. BioDrugs 37, 311\u2013329 (2023).","journal-title":"BioDrugs"},{"key":"4505_CR35","doi-asserted-by":"publisher","unstructured":"Muhuri, M. et al. Overcoming innate immune barriers that impede AAV gene therapy vectors. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci143780 (2021).","DOI":"10.1172\/jci143780"},{"key":"4505_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","volume":"388","author":"J Bennett","year":"2016","unstructured":"Bennett, J. et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet 388, 661\u2013672 (2016).","journal-title":"Lancet"},{"key":"4505_CR37","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1097\/AUD.0000000000001525","volume":"45","author":"TY Fang","year":"2024","unstructured":"Fang, T. Y. et al. Validation of the Chinese version of the speech, spatial, and qualities of hearing scale for parents and children. Ear Hear 45, 1362\u20131368 (2024).","journal-title":"Ear Hear"},{"key":"4505_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101456","volume":"33","author":"Y Ishibashi","year":"2025","unstructured":"Ishibashi, Y. et al. AAV-mediated inner ear gene delivery triggers mild host immune responses in the mammalian inner ear. Mol. Ther. Methods Clin. Dev. 33, 101456 (2025).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4505_CR39","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","volume":"101","author":"CS Manno","year":"2003","unstructured":"Manno, C. S. et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101, 2963\u20132972 (2003).","journal-title":"Blood"},{"key":"4505_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101420","volume":"33","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing. Mol. Ther. Methods Clin. Dev. 33, 101420 (2025).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4505_CR41","first-page":"1760","volume":"14","author":"Q Li","year":"2008","unstructured":"Li, Q. et al. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol. Vis. 14, 1760\u20131769 (2008).","journal-title":"Mol. Vis."},{"key":"4505_CR42","doi-asserted-by":"publisher","first-page":"21ra16","DOI":"10.1126\/scitranslmed.3000659","volume":"2","author":"D Amado","year":"2010","unstructured":"Amado, D. et al. Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. Sci. Transl. Med. 2, 21ra16 (2010).","journal-title":"Sci. Transl. Med."},{"key":"4505_CR43","doi-asserted-by":"publisher","first-page":"120ra115","DOI":"10.1126\/scitranslmed.3002865","volume":"4","author":"J Bennett","year":"2012","unstructured":"Bennett, J. et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci. Transl. Med. 4, 120ra115 (2012).","journal-title":"Sci. Transl. Med."},{"key":"4505_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.gt.3303037","volume":"15","author":"H Petry","year":"2008","unstructured":"Petry, H. et al. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice. Gene Ther. 15, 54\u201360 (2008).","journal-title":"Gene Ther."},{"key":"4505_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3505","volume":"25","author":"N Baatartsogt","year":"2023","unstructured":"Baatartsogt, N. et al. Successful liver transduction by re-administration of different adeno-associated virus vector serotypes in mice. J. Gene Med. 25, e3505 (2023).","journal-title":"J. Gene Med."},{"key":"4505_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/01926233231202995","volume":"51","author":"S Chandra","year":"2023","unstructured":"Chandra, S. et al. Safety findings of dosing gene therapy vectors in NHP with pre-existing or treatment-emergent anti-capsid antibodies. Toxicol. Pathol. 51, 246\u2013256 (2023).","journal-title":"Toxicol. Pathol."},{"key":"4505_CR47","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.omtm.2020.05.007","volume":"17","author":"R Omichi","year":"2020","unstructured":"Omichi, R., Yoshimura, H., Shibata, S. B., Vandenberghe, L. H. & Smith, R. J. H. Hair cell transduction efficiency of single- and dual-AAV serotypes in adult murine cochleae. Mol. Ther. Methods Clin. Dev. 17, 1167\u20131177 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4505_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41434-023-00431-z","volume":"31","author":"S Han","year":"2024","unstructured":"Han, S. et al. Distributional comparison of different AAV vectors after unilateral cochlear administration. Gene Ther. 31, 154\u2013164 (2024).","journal-title":"Gene Ther."},{"key":"4505_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.omtm.2020.04.001","volume":"17","author":"K Bey","year":"2020","unstructured":"Bey, K. et al. Intra-CSF AAV9 and AAVrh10 administration in nonhuman primates: promising routes and vectors for which neurological diseases? Mol. Ther. Methods Clin. Dev. 17, 771\u2013784 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4505_CR50","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1007\/s12035-018-1366-4","volume":"56","author":"Y Shinohara","year":"2019","unstructured":"Shinohara, Y. et al. Effects of neutralizing antibody production on AAV-PHP.B-mediated transduction of the mouse central nervous system. Mol. Neurobiol. 56, 4203\u20134214 (2019).","journal-title":"Mol. Neurobiol."},{"key":"4505_CR51","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nri.2017.100","volume":"17","author":"I Spadoni","year":"2017","unstructured":"Spadoni, I., Fornasa, G. & Rescigno, M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat. Rev. Immunol. 17, 761\u2013773 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"4505_CR52","doi-asserted-by":"publisher","unstructured":"Yi, Z., Wang, X., Yin, G. & Sun, Y. The blood-labyrinth barrier: non-invasive delivery strategies for inner ear drug delivery. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics17040482 (2025).","DOI":"10.3390\/pharmaceutics17040482"},{"key":"4505_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.heares.2017.12.009","volume":"362","author":"BH Hu","year":"2018","unstructured":"Hu, B. H., Zhang, C. & Frye, M. D. Immune cells and non-immune cells with immune function in mammalian cochleae. Hear. Res. 362, 14\u201324 (2018).","journal-title":"Hear. Res."},{"key":"4505_CR54","doi-asserted-by":"publisher","unstructured":"Asp, F., Karltorp, E. & Berninger, E. Development of sound localization in infants and young children with cochlear implants. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11226758 (2022).","DOI":"10.3390\/jcm11226758"},{"key":"4505_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2024.112031","volume":"183","author":"P Jaisinghani","year":"2024","unstructured":"Jaisinghani, P., Yoon, Y. S., Chun, Y. M. & Shin, Y. R. Impact of age at the second implantation, experience of amplification use, and long-term binaural experience on sound localization of children with bilateral cochlear implants. Int. J. Pediatr. Otorhinolaryngol. 183, 112031 (2024).","journal-title":"Int. J. Pediatr. Otorhinolaryngol"},{"key":"4505_CR56","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731\u20132738 (2004).","journal-title":"J. Immunol."},{"key":"4505_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00439-022-02504-2","volume":"142","author":"H Tang","year":"2023","unstructured":"Tang, H. et al. Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin. Hum. Genet. 142, 289\u2013304 (2023).","journal-title":"Hum. Genet."},{"key":"4505_CR58","doi-asserted-by":"publisher","unstructured":"Donovan, J. & Brown, P. Blood collection. Curr. Protoc. Neurosci. https:\/\/doi.org\/10.1002\/0471142301.nsa04gs33 (2005).","DOI":"10.1002\/0471142301.nsa04gs33"},{"key":"4505_CR59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-022-00995-z","volume":"7","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB). Signal Transduct. Target Ther. 7, 175 (2022).","journal-title":"Signal Transduct. Target Ther"},{"key":"4505_CR60","doi-asserted-by":"publisher","unstructured":"Lim, N. K. et al. An Improved method for collection of cerebrospinal fluid from anesthetized mice. J. Vis. Exp. https:\/\/doi.org\/10.3791\/56774 (2018).","DOI":"10.3791\/56774"},{"key":"4505_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/glia.23563","volume":"67","author":"B Linnartz-Gerlach","year":"2019","unstructured":"Linnartz-Gerlach, B. et al. TREM2 triggers microglial density and age-related neuronal loss. Glia 67, 539\u2013550 (2019).","journal-title":"Glia"},{"key":"4505_CR62","doi-asserted-by":"publisher","unstructured":"Ouyang, Y. et al. Polysialic acid-functionalized MAP scaffolds promote regulatory immune responses after ischemic stroke. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.09.10.674054 (2025).","DOI":"10.1101\/2025.09.10.674054"},{"key":"4505_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuron.2018.08.030","volume":"100","author":"L Duan","year":"2018","unstructured":"Duan, L. et al. PDGFR\u03b2 cells rapidly relay inflammatory signal from the circulatory system to neurons via chemokine CCL2. Neuron 100, 183\u2013200 (2018).","journal-title":"Neuron"},{"key":"4505_CR64","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41586-026-10393-y","volume":"653","author":"L Jiang","year":"2026","unstructured":"Jiang, L. et al. Multicentre gene therapy for OTOF-related deafness followed up to 2.5 years. Nature 653, 1170\u20131177 (2026).","journal-title":"Nature"},{"key":"4505_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1179\/1754762812Y.0000000014","volume":"14","author":"KL Galvin","year":"2013","unstructured":"Galvin, K. L. & Noble, W. Adaptation of the speech, spatial, and qualities of hearing scale for use with children, parents, and teachers. Cochlear Implants Int. 14, 135\u2013141 (2013).","journal-title":"Cochlear Implants Int."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04505-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:01:43Z","timestamp":1786629703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04505-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4505"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04505-4","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.-Y.C. is a cofounder of Salubritas Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}